Abstract
Lower respiratory tract infections (LRTI) account for 20–30 % of all hospital-acquired contagions. They are characterized by high mortality of hospitalized patients. The most serious form of LRTI is pneumonia, and the most common etiological factors in such cases are bacteria. The article gives the analysis of bacterial flora samples obtained from lower respiratory tract of hospitalized patients. In vitro susceptibility of pathogens to selected antibiotics has also been assessed. We carried out a retrospective analysis of 1,171 bacterial strains isolated from 1,171 patients treated in clinics of the Military Institute of Medicine in Warsaw, Poland. In most cases the samples were collected from an endotracheal or tracheostomic tube (71.5 %) and from bronchoalveolar lavage (21.7 %). The most commonly isolated pathogens included Acinetobacter baumannii (35.8 %), Staphylococcus aureus (27.6 %), Klebsiella pneumoniae (19.4 %), and Pseudomonas aeruginosa (16.2 %). Multidrug-resistant gram-negative bacteria exhibited 100 % susceptibility to colistin only. Klebsiella pneumoniae ESBL+ and Acinetobacter baumannii were most susceptible to carbapenems, while Pseudomonas aeruginosa strains to ceftazidime. Methicillin-resistant Staphylococcus aureus were 100 % susceptible to vancomycin, linezolid, and tigecycline. In conclusion, identifying the etiological factors causing infections of the lower respiratory tract and determining their drug-susceptibility is of key importance in empirical treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Thoracic Society (1996) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy and preventive strategies. A consensus statement. Am J Respir Crit Care Med 153(5):1711–1725
American Thoracic Society (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171(4):388–416
Canadian Critical Care Trials Group (2006) A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 355(25):2619–2630
Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Agusti-Vidal A (1988) Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 93(2):318–324
Clinical and Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement M100-S18. CLSI, Wayne. Accessed 12 Aug 2011
Duszyńska W (2010) Antimicrobial therapy in severe infections with multidrug-resistant Gram-negative bacteria’s. Anestezjol Intens Ter 42(3):160–166
European Committee on Antimicrobial Susceptibility Testing (2011) EUCAST criteria. Available from: http://www.eucast.org. Accessed 12 Aug 2011
Goulding J, Snelgrove R, Saldana J, Didierlaurent A, Cavanagh M, Gwyer E, Wales J, Wissinger EL, Hussell T (2007) Respiratory infections: do we ever recover? Proc Am Thorac Soc 4(8):618–625
Hryniewicz W, Ozorowski T (2011) Hospital list of antibiotics. National Medicines Institute, Warszawa, pp 19–22
Hryniewicz W, Grzesiowski P, Kozielski J, Kuś J, Meszaros J, Ozorowski T, Pirożyński M, Płusa T, Radzikowski A (2008) Recommendations for diagnostics and treatment of respiratory tract infections. National Program of Antibiotic Protection, Warszawa, pp 5–7
Intensive Care Antimicrobial Resistance Epidemiology (1996) Surveillance report, data summary from January 1996 through December 1997: a report from the National Nosocomial Infections Surveillance System. Am J Infect Control 27(3):279–287
Kelesidis T, Karageorgopoulos DE, Kelesidis I, Falagas ME (2008) Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother 62(5):895–904
Kowalczyk W, Rybicki Z, Tomaszewski D, Truszczyński A, Guzek A (2011) The comparison of different bronchial aspirate culturing methods in patients with ventilator-associated pneumonia (VAP). Anestezjol Intens Ter 43(2):74–79
Lim WS, Macfarlane JT (2001) A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 18(2):362–368
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak M, Talan DA, Chambers HF (2011) Clinical practice guidelines by the Infectious Diseases Society of America for treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52(3):18–55
National Reference Center for Antimicrobial Susceptibility (2013) National Medicines Institute. National Laboratory of Medicinal Products, Medical Devices and Biocidal Products Control, Warsaw. Available from: http://www.il.waw.pl/eng/ZE.html. Accessed 10 Aug 2013
Płusa T (2013) Severe respiratory tract infections and rational antibiotic therapy. Int Rev Allergol Clin Immunol 1:7–11
Rello J, Ulldemolins M, Lisboa T, Koulenti D, Manez R, Martin-Loeches I, De Waele JJ, Putensen C, Guven M, Deja M, Diaz E (2011) Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. Eur Respir J 37(6):1332–1339
Rybicki Z (2012) Antibiotherapy in the treatment of hospital acquired infections. Makmed, Lublin, pp 222–224
Acknowledgments
We thank Dr. Andrzej Truszczyński from the Clinic of Anesthesiology and Intensive Care of the Military Institute of Medicine in Warsaw for his support during collecting the data. This work was supported by the Polish Ministry of Science and High Education (Theme no. 222/213, Military Institute of Medicine in Warsaw, Poland).
Conflicts of Interest
The authors declare no conflict of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Guzek, A. et al. (2014). Etiological Factors Causing Lower Respiratory Tract Infections Isolated from Hospitalized Patients. In: Pokorski, M. (eds) Respiratory Infections. Advances in Experimental Medicine and Biology(), vol 835. Springer, Cham. https://doi.org/10.1007/5584_2014_23
Download citation
DOI: https://doi.org/10.1007/5584_2014_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-10014-2
Online ISBN: 978-3-319-10015-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)